Medical HIGH

Pennsylvania

Despite Governor Josh Shapiro's repeated executive budget proposals to legalize adult-use cannabis, the Pennsylvania legislature remains deeply divided between a Democratic House favoring a state-run store model and a Republican Senate favoring private enterprise or continued prohibition.
Pennsylvania hosts one of the nation's largest medical cannabis programs, generating $1.8 billion in sales in 2025 and serving approximately 440,000 active patients, though patient numbers have recently plateaued.
With nearly all neighboring states (except West Virginia) operating legal adult-use markets, research suggests that up to 60% of consumers at certain New Jersey border dispensaries are Pennsylvania residents, resulting in significant outward capital flow.
Cannabis possession remains a criminal misdemeanor at the state level, resulting in over 11,000 arrests in 2024. The data indicates severe racial disparities, with Black residents significantly more likely to face arrest for possession than white residents.

The trajectory of adult-use cannabis legalization in Pennsylvania is highly complex. The evidence leans toward an eventual legislative compromise, given the mounting fiscal pressure and the reality of cross-border purchasing. In May 2025, the Pennsylvania House passed the Cannabis Health and Safety Act (HB 1200) by a razor-thin 102-101 margin, proposing a novel framework where private entities cultivate the product, but retail sales are exclusively handled by state-run stores under the Liquor Control Board. However, this approach faces intense skepticism in the Senate, where Republican leadership has categorized the state-store model as unworkable and prefers oversight by an independent Cannabis Control Board. From an economic standpoint, the state's Independent Fiscal Office projects that a regulated adult-use market could generate over $432 million annually by 2030, while the Governor's office has projected $729 million in the first year, largely reliant on one-time licensing fees. Meanwhile, thousands of citizens continue to be entangled in the criminal justice system.

Medical

Medical Program

Medical Status: Legal. The medical cannabis program was established by Act 16 (the Medical Marijuana Act) in April 2016 and expanded via Act 44 in 2021. Registered patients may possess a 90-day supply. Legal forms include pills, oils, topicals, tinctures, liquids, and dry flower (for vaporization only). Combustion/smoking of flower and edible cannabis products remain explicitly prohibited under the state medical program.^[7]
Medical Sales: $1.8B^[2]
Dispensaries: 185–195^[3]

Pennsylvania's medical cannabis market is one of the largest in the United States, generating $1.8 billion in retail sales in 2025. Cumulatively, the state has recorded $8.5 billion in medical retail sales since program inception as of December 2025. The program serves approximately 439,400 active registered patients as of November 2025, having peaked at approximately 446,480 in April 2025 before a minor contraction. Over 1 million unique patients have registered since the program launched. The market is heavily dominated by multi-state operators including Trulieve (21 stores), GTI (18 stores), Cresco Labs, Curaleaf, and Verano. Specific market share percentages are not publicly disclosed. Prices have compressed to historic lows: $2.98/gram wholesale and $7.59/gram retail as of late 2025.

Penalties (Outside Medical Program)

Offense	Amount	Classification	Penalty
Possession	30 grams or less of flower, or 8 grams or less of hashish	Misdemeanor	Up to 30 days in jail and a $500 fine. First-time offenders often eligible for conditional release (probation). ^[18]
Possession	More than 30 grams	Misdemeanor	Up to 1 year in jail and a $5,000 fine. ^[16]
Sale/Distribution	More than 30 grams	Felony	2.5 to 5 years in prison and a $15,000 fine for a first offense. Penalties double for repeat offenders or if sold to a minor. ^[18]
Home Cultivation	Any amount without commercial license	Felony	2.5 to 5 years in prison and up to $15,000 in fines. ^[18]

Criminal Justice

Group	Metric	Value
Black	Disparity Ratio	4.7x more likely to be arrested for cannabis possession than white counterparts (2021 data)
Black	Disparity Ratio (historical high)	Up to 8-to-1 statewide in historical ACLU reports; greater than 6-to-1 in Allegheny County, despite nearly identical usage rates among racial demographics ^[27]

Pennsylvania continues to aggressively prosecute cannabis offenses. In 2024, law enforcement made 11,154 arrests for simple possession and 1,553 arrests for sales and manufacturing, totaling 12,707 arrests. Over the past decade, the state has logged over 154,000 possession arrests. Black adults are 4.7 times more likely to be arrested for cannabis possession than white counterparts (2021 data), with historical ACLU reports showing disparities as high as 8-to-1 statewide. Expungement is not automatic; the Marijuana Pardon Project addresses eligible cases but faces administrative bottlenecks.

What Pennsylvania Is Leaving on the Table

If Pennsylvania had adult-use cannabis sales at the level of operational states:

Benchmark	Per Capita	Rank	Estimated PA Market
Connecticut (#20)	$60.73	Lowest	$793M
New Jersey (#15)	$126.23	Mid-pack	$1.6B
Colorado (#9)	$196.26	Mature	$2.6B

Based on total state population and per capita sales from operational markets. Actual results vary by market design, tax structure, licensing speed, and border dynamics. See how all 20 legal states compare →

Borders

Border Dynamics

Neighbor	Legal Status	Notes
New York	Adult-Use Operational	Legal adult-use market
New Jersey	Adult-Use Operational	Approximately 60% of customers at border dispensaries are Pennsylvania residents. NJ dispensaries heavily market on billboards along I-95 toward Philadelphia.
Delaware	Adult-Use Operational	Legal adult-use market
Maryland	Adult-Use Operational	Northern border dispensaries see heavy traffic from southern Pennsylvania.
Ohio	Adult-Use Operational	Legal adult-use market
West Virginia	Medical Only	Only neighboring state without adult-use legalization

Pennsylvania is effectively a policy island. Every bordering state except West Virginia has legalized adult-use cannabis. The cross-border purchasing dynamic is profound: approximately 60% of customers at certain NJ and Maryland border dispensaries are Pennsylvania residents. Nearly half of Pennsylvania's population lives in a county directly bordering an adult-use state. NJ dispensaries advertise heavily on billboards along I-95 toward Philadelphia. Pennsylvania State Police enforce that transporting legally purchased out-of-state cannabis across the border is a federal trafficking offense.

Economic

Economic Opportunity

Fiscal Note: Governor's 2026-27 estimate: $729 million in Year 1 (assuming Jan 1, 2027 start), but $660 million of that is one-time upfront licensing fees with recurring annual tax revenue stabilizing around $200 million. Independent Fiscal Office (nonpartisan): $140 million in Year 1 (2027-2028), scaling to $432 million annually by 2030-2031, assuming a 20% wholesale excise tax and standard 6% retail sales tax. The IFO notes PA will not capture cannabis tourism due to mature border markets — only domestic repatriation.^[9]
Neighbor Revenue: Approximately 60% of customers at NJ and Maryland border dispensaries are Pennsylvania residents. Nearly half of Pennsylvania's population lives in a county directly bordering an adult-use state, representing significant outward capital flow.^[37]
Jobs Estimate: FTI Consulting projects legalization could support between 26,250 and 44,500 jobs within the Commonwealth.

A mature adult-use market in Pennsylvania could generate $2.8 billion in annual retail sales, per advocacy and economic analyses. The Governor's office projects $729 million in Year 1 tax revenue, though this is heavily inflated by $660 million in proposed one-time licensing fees. The nonpartisan Independent Fiscal Office projects a more conservative $140 million in Year 1 scaling to $432 million by 2030-31. Tax stacking concerns — cumulative rates keeping legal prices uncompetitive against illicit and border markets — are raised by market analysts. FTI Consulting projects 26,250 to 44,500 jobs from legalization.

Political

Political Trajectory

Active Bills: HB 1200 (Cannabis Health and Safety Act): Sponsored by Reps. Rick Krajewski (D) and Dan Frankel (D). Hybrid marketplace — private cultivation, state-run retail via the PA Liquor Control Board. Passed House, stalled in Senate. SB 49 / SB 120: Authored by Republican Sen. Dan Laughlin. Establishes an independent Cannabis Control Board; prioritizes private enterprise over state-run stores.^[1]
Polling Support: 56% of registered Pennsylvania voters support adult-use legalization; 37% oppose. Support is highly partisan: 72% of Democrats, 63% of Independents support; 63% of Republicans oppose.^[34]

The legislative pathway is locked in a structural stalemate. House Democrats insist on state-run stores to capture maximum revenue and control public health; Senate Republicans refuse to expand state-run monopolies. Bipartisan agreement exists that the state is losing massive revenue to New Jersey and Maryland, but the mechanisms are diametrically opposed. Meaningful movement requires a negotiated compromise substituting state-run stores for a private framework overseen by a new regulatory board.